Stay updated on Immunotherapy in Stage IV Melanoma Patients Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the older government funding/operating status notice (v3.4.1). These are routine site maintenance updates that do not alter the study details.
    Difference
    0.4%
    Check dated 2026-02-11T02:35:59.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide funding notice was added (notifying about a lapse in government funding and directing users to cc.nih.gov and opm.gov) and the page revision tag updated from v3.4.0 to v3.4.1, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T01:31:01.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The update adds a Show glossary option and a new PDF study protocol (Study Protocol and Statistical Analysis Plan), along with expanded Study Documents and Locations/Investigators sections. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    61%
    Check dated 2026-01-27T23:30:56.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T19:16:48.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations section added with state-specific sites (Illinois, Iowa, Kansas, North Carolina, and Tennessee) and page revision updated to v3.3.3. The HHS Vulnerability Disclosure link and several location sections were removed.
    Difference
    0.6%
    Check dated 2025-12-23T09:19:06.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1; no visible changes to study details, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:49:37.000Z thumbnail image

Stay in the know with updates to Immunotherapy in Stage IV Melanoma Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.